Division of GI Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, 5150 Center Avenue, Pittsburgh, PA 15213, USA.
Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):468-76. doi: 10.1038/nrgastro.2012.120. Epub 2012 Jun 26.
Pancreatic surgery is challenging for both surgeon and patient. With the advent of minimally invasive surgical techniques, patient morbidity could be reduced. However, these techniques must conform to established principles of open pancreatic surgery with regards to meticulous dissection, haemostasis and oncologic results. The robotic platform is utilized in all facets of surgery, and is being increasingly applied in pancreatic surgery. As with the introduction of any new technology, this approach must undergo rigorous examination before widespread adoption of the technique. In this article, we review the techniques and outcomes of robotic-assisted pancreatic resections, focusing on robotic-assisted pancreaticoduodenectomy, robotic-assisted distal pancreatectomy and robotic-assisted central pancreatectomy. As the outcomes of robotic-assisted surgery have yet to be rigorously evaluated against the gold standard of open surgery, this Review also highlights major laparoscopic pancreatic series in an effort to summarize the available literature on minimally invasive pancreatic surgery.
胰腺手术对外科医生和患者都是具有挑战性的。随着微创外科技术的出现，患者的发病率可能会降低。然而，这些技术必须符合开放胰腺手术的既定原则，包括精细解剖、止血和肿瘤学结果。机器人平台用于手术的各个方面，并越来越多地应用于胰腺手术。与任何新技术的引入一样，在广泛采用该技术之前，必须对其进行严格检查。本文回顾了机器人辅助胰腺切除术的技术和结果，重点介绍了机器人辅助胰十二指肠切除术、机器人辅助胰体尾切除术和机器人辅助胰中段切除术。由于机器人辅助手术的结果尚未经过严格评估与开放手术的金标准相比，因此本综述还强调了主要的腹腔镜胰腺系列，以努力总结微创胰腺手术的现有文献。
